Michael Bishop, MD
Radiation Oncology · Lima, OHNPI 1548607278
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,400 of the $1,962 with a category attached, or 71.4%. ADC Therapeutics America, Inc. accounts for 71.4% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2024 at $1,413 and has fallen 91.6% since, to $119 in 2025.
Across 18 payments — averaging $108.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ADC Therapeutics America, Inc.$1K
- Regeneron Healthcare Solutions, Inc.$149
- Varian Medical Systems, Inc.$94
- Medtronic$87
- Siemens Medical Solutions USA, Inc.$66
- Boston Scientific$62
- plus $105 from 6 others
What the payments were for
- Consulting fees$1,40071%
- Food & beverage$54928%
- Education$131%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ADC Therapeutics America, Inc. | 1 | $1,400 |
| Regeneron Healthcare Solutions, Inc. | 4 | $149 |
| Varian Medical Systems, Inc. | 1 | $94 |
| Medtronic | 1 | $87 |
| Siemens Medical Solutions USA, Inc. | 2 | $66 |
| Boston Scientific | 3 | $62 |
| Accuray Incorporated | 1 | $25 |
| Bayer | 1 | $19 |
| Incyte Corporation | 1 | $17 |
| Sanofi | 1 | $16 |
| Foundation Medicine, Inc. | 1 | $15 |
| Z-medica, LLC | 1 | $12 |
How this compares
$1,962 in reported general payments places this provider in the 75th percentile of 255 radiation oncology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Betamethasone Valerate | 17 | $369 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Lima
- Steven KurtzmanGarfield Heights$833K
- Joshua PalmerColumbus$123K
- Norleena PoynterSandusky$90K
- Daniel SprattCleveland$86K
- Shlomo KoyfmanCleveland$72K
- Gerald SokolCleveland$61K
- Peter FriedFairfield$45K
- Rahul TendulkarCleveland$26K
- Sujith BaligaColumbus$26K
- Anthony ParavatiKettering$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.